Several studies have reported that melatonin is recommended for the treatment of chronic inflammatory skin diseases, such as atopic dermatitis (AD), thanks to its abilities to reduce inflammatory parameters, such as serum C-reactive protein (CRP) levels and IL-4 and IFN-γ production, in patients with AD [52,53]. The gene discussed is IL4; the disease is atopic eczema.